• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Femasys Inc (NQ: FEMY )

    1.140 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 53
    Open 1.140
    Bid (Size) 1.120 (3)
    Ask (Size) 1.150 (1)
    Prev. Close 1.140
    Today's Range 1.140 - 1.140
    52wk Range 0.7340 - 3.130
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Announces Infertility Clinic Customers from Coast to Coast
    Leading medical clinics become key regional resources to offer FemaSeed infertility treatment 
    From Femasys Inc.
    Via GlobeNewswire

    Performance

    YTD
    +12.87%
    +12.87%
    1 Month
    +4.59%
    +4.59%
    3 Month
    +3.64%
    +3.64%
    6 Month
    -37.02%
    -37.02%
    1 Year
    -54.22%
    -54.22%

    More News

    Read More
    Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
    Via Benzinga
    Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
    From Femasys Inc.
    Via GlobeNewswire
    Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting
    From Femasys Inc.
    Via GlobeNewswire
    Deep Dive Into Femasys Stock: Analyst Perspectives (4 Ratings)
    Via Benzinga
    Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. at August 20th Virtual Investor Summit Microcap Event
    Via ACCESSWIRE
    FEMY Stock Earnings: Femasys Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
    From Femasys Inc.
    Via GlobeNewswire
    Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Gold Rises 1%; Accenture Shares Surge After Q3 Results
    Via Benzinga
    Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe
    From Femasys Inc.
    Via GlobeNewswire
    EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says
    Via Benzinga
    Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
    From Femasys Inc.
    Via GlobeNewswire
    Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
    From Femasys Inc.
    Via GlobeNewswire
    FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.